Second cancer risk in hairy cell leukemia: analysis of 350 patients

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
R KurzrockM Talpaz

Abstract

The discovery of effective therapy for hairy cell leukemia (HCL) has increased the relevance of long-term outcome. We have therefore examined the incidence of second cancers. Data on 350 HCL patients was obtained from the M.D. Anderson Cancer Center Cancer Registry's computerized data base and from chart review. Standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) (observed/expected [O/E]) were calculated with the expected number determined using age, sex, and calendar-year-specific rates from the Connecticut Tumor Registry and from national mortality data, respectively. The median age of the patients was 50 years and the median follow-up duration was 6 years. Twenty-six patients developed a second cancer at least 6 months after the HCL diagnosis (O/E ratio, 1.34; P = .08). There was no excess of malignancy among patients treated with interferon alfa (IFN-alpha; P = .27), 2-chlorodeoxyadenosine (2CDA; P = .37), or deoxycoformycin (DCF; P = .7). However, an excess of myeloma-related neoplasms (O/E, 13.04; P < .001) and lymphomas (O/E, 8.7; P = .03) was observed. Survival from the advent of systemic therapy for HCL was better than before this time (P = .0009). Nevertheless, mortality remained excessive (O...Continue Reading

Citations

Nov 9, 2001·Leukemia & Lymphoma·B UndarG H Ozsan
Nov 4, 2004·European Journal of Haematology·Giulia CervettiMario Petrini
Oct 28, 2016·British Journal of Haematology·Bartlomiej M GettaMartin S Tallman
Jun 12, 2002·Current Treatment Options in Oncology·L Savoie, J B Johnston
Dec 1, 2006·British Journal of Hospital Medicine·Archana RaoM Jean Goodrick
Nov 17, 2006·Leukemia & Lymphoma·Adi Gidron, Martin S Tallman
Jan 3, 2001·Hematological Oncology·W Y AuR Liang
Nov 8, 2001·Leukemia & Lymphoma·M W Saif, B R Greenberg
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B D ChesonB Freidlin
Dec 14, 2005·European Journal of Haematology·T RimnerA Gratwohl
Oct 11, 2007·Current Treatment Options in Oncology·Rossella RiccioniMario Petrini
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Massimo FedericoUNKNOWN Italian Cooperative Group for the Study of Hairy Cell Leukemia
Oct 21, 2009·Leukemia & Lymphoma·Edward HuynhAlan Saven
Aug 26, 2014·Expert Review of Hematology·Zheng Z Topp, Alan Saven
Jun 5, 2010·Journal of Gastrointestinal Cancer·Nikolaos S SalemisCharalambos Christofyllakis
Feb 26, 2015·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Frank J Senatore, Constantin A Dasanu
May 29, 2020·Blood Cancer Journal·Jerome PaillassaXavier Troussard
Jun 24, 2004·Expert Opinion on Pharmacotherapy·Francesco Lauria, Francesco Forconi
Nov 19, 2009·Journal of Neurology·Hans-Peter HartungGiancarlo Comi Giancarlo Comi
Apr 23, 2014·British Journal of Haematology·Edouard CornetUNKNOWN Société Française d'Hématologie
Oct 19, 2006·European Journal of Haematology·Ora PaltielEldad J Dann
Aug 12, 1999·British Journal of Haematology·A R PettittJ C Cawley
Jun 29, 2004·International Journal of Hematology·James O ArmitageMathias J Rummel
Feb 1, 2007·Annals of Saudi Medicine·M W SaifB Greenberg
Mar 1, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Grant R GoodmanAlan Saven
Nov 21, 2020·Annals of Hematology·Ewa RobakTadeusz Robak
Apr 3, 2003·Best Practice & Research. Clinical Haematology·Anaadriana ZakarijaMartin S Tallman
Apr 10, 2003·Archives of Pathology & Laboratory Medicine·Ellen SchletteCarlos E Bueso-Ramos

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Massimo FedericoItalian Cooperative Group for the Study of Hairy Cell Leukemia
Annals of Saudi Medicine
M W SaifB Greenberg
Indian Journal of Pathology & Microbiology
T SinghS Prakash
Arkhiv patologii
R D Shteri
© 2021 Meta ULC. All rights reserved